Follistim AQ Cartridge Purple Book BLA 021211

BLA number
021211
Proprietary names
Follistim AQ Cartridge
Proper names
follitropin beta
Applicant
Organon USA LLC, a subsidiary of Organon & Co.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Follistim AQ Cartridgefollitropin beta351(a)300IU/0.36MLInjectionSubcutaneousMulti-Dose CartridgeRxLicensed2004-03-23
002Follistim AQ Cartridgefollitropin beta351(a)600IU/0.72MLInjectionSubcutaneousMulti-Dose CartridgeRxLicensed2004-03-23
003Follistim AQ Cartridgefollitropin beta351(a)175IU/0.21MLInjectionSubcutaneousMulti-Dose CartridgeDiscVoluntarily Revoked2005-02-11
004Follistim AQ Cartridgefollitropin beta351(a)900IU/1.08MLInjectionSubcutaneousMulti-Dose CartridgeRxLicensed2005-02-11

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-04-01U003Follistim AQ Cartridge351(a)DiscOrganon USA LLC, a subsidiary of Organon & Co.
2023-09-01U001Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-09-01U002Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-09-01U003Follistim AQ Cartridge351(a)DiscOrganon USA LLC, a subsidiary of Organon & Co.
2023-09-01U004Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-08-01U001Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-08-01U002Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-08-01U003Follistim AQ Cartridge351(a)DiscOrganon USA LLC, a subsidiary of Organon & Co.
2023-08-01U004Follistim AQ Cartridge351(a)RxOrganon USA LLC, a subsidiary of Organon & Co.
2023-03-01U001Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2023-03-01U002Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2023-03-01U004Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2021-09-01U003Follistim AQ Cartridge351(a)DiscOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2020-05-01R001Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2020-05-01R002Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2020-05-01R003Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.
2020-05-01R004Follistim AQ Cartridge351(a)RxOrganon USA Inc., a subsidiary of Merck & Co., Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2026-04-01003Follistim AQ Cartridge351(a)DiscVoluntarily Revoked2005-02-11
2021-09-01003Follistim AQ Cartridge351(a)DiscLicensed2005-02-11
2021-08-01001Follistim AQ Cartridge351(a)RxLicensed2004-03-23
2021-07-01001Nikia Morris; cover letter from 5/7/21 submission351(a)RxLicensed2004-03-23
2020-05-01001Follistim AQ Cartridge351(a)RxLicensed2004-03-23
2020-05-01002Follistim AQ Cartridge351(a)RxLicensed2004-03-23
2020-05-01003Follistim AQ Cartridge351(a)RxLicensed2005-02-11
2020-05-01004Follistim AQ Cartridge351(a)RxLicensed2005-02-11